EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report

Objective To describe the methodology used to develop new classification criteria for adult and juvenile idiopathic inflammatory myopathies (IIMs) and their major subgroups. Methods An international, multidisciplinary group of myositis experts produced a set of 93 potentially relevant variables to be tested for inclusion in the criteria. Rheumatology, dermatology, neurology and paediatric clinics worldwide collected data on 976 IIM cases (74% adults, 26% children) and 624 non-IIM comparator cases with mimicking conditions (82% adults, 18% children). The participating clinicians classified each case as IIM or non-IIM. Generally, the classification of any given patient was based on few variables, leaving remaining variables unmeasured. We investigated the strength of the association between all variables and between these and the disease status as determined by the physician. We considered three approaches: (1) a probability-score approach, (2) a sum-of-items approach criteria and (3) a classification-tree approach. Results The approaches yielded several candidate models that were scrutinised with respect to statistical performance and clinical relevance. The probability-score approach showed superior statistical performance and clinical practicability and was therefore preferred over the others. We developed a classification tree for subclassification of patients with IIM. A calculator for electronic devices, such as computers and smartphones, facilitates the use of the European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria. Conclusions The new EULAR/ACR classification criteria provide a patient’s probability of having IIM for use in clinical and research settings. The probability is based on a score obtained by summing the weights associated with a set of criteria items.

[1]  M. Guiguet,et al.  Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies , 2018, JAMA neurology.

[2]  P. Lachenbruch,et al.  2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups , 2017, Annals of the rheumatic diseases.

[3]  中山 優吏佳 Cincinnati Children’s Hospital Medical Centerでの海外実習を終えて , 2017 .

[4]  A. Martini,et al.  Consensus procedures and their role in pediatric rheumatology , 2008, Current rheumatology reports.

[5]  M. Dougados,et al.  Classification criteria for rheumatic diseases: why and how? , 2007, Arthritis and rheumatism.

[6]  M. Dougados,et al.  Development of classification and response criteria for rheumatic diseases. , 2006, Arthritis and rheumatism.

[7]  I. Targoff,et al.  Novel Classification of Idiopathic Inflammatory Myopathies Based on Overlap Syndrome Features and Autoantibodies: Analysis of 100 French Canadian Patients , 2005, Medicine.

[8]  A. Pestronk,et al.  Polymyositis: An overdiagnosed entity , 2004, Neurology.

[9]  R. Hughes,et al.  119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands , 2004, Neuromuscular Disorders.

[10]  H. Burger,et al.  Polymyositis , 2003, Neurology.

[11]  F. Mastaglia,et al.  Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. , 2002, Rheumatic diseases clinics of North America.

[12]  J. Habbema,et al.  Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. , 2001, Journal of clinical epidemiology.

[13]  T. Medsger,et al.  Classification criteria for the idiopathic inflammatory myopathies. , 1997, Current opinion in rheumatology.

[14]  M. Dalakas,et al.  Inclusion body myositis and myopathies , 1997, Journal of the Neurological Sciences.

[15]  T. Sato,et al.  Classification criteria for polymyositis and dermatomyositis. , 1995, The Journal of rheumatology.

[16]  M. Dalakas Polymyositis, dermatomyositis and inclusion-body myositis. , 1991, The New England journal of medicine.

[17]  R. Brook,et al.  Consensus methods: characteristics and guidelines for use. , 1984, American journal of public health.

[18]  D. Rubin INFERENCE AND MISSING DATA , 1975 .

[19]  A. V. D. Ven,et al.  The Effectiveness of Nominal, Delphi, and Interacting Group Decision Making Processes , 1974 .

[20]  W. N. Dawson,et al.  The epidemiology of polymyositis. , 1970, The American journal of medicine.

[21]  H. Yoshida Tokyo, Japan , 2019, The Statesman’s Yearbook Companion.

[22]  Vicky Totikidis Applying the Nominal Group Technique (NGT) in Community Based Action Research for Health Promotion and Disease Prevention , 2010 .

[23]  T. Brannagan,et al.  Polymyositis and dermatomyositis , 2002 .

[24]  L. Breiman Random Forests , 2001, Machine Learning.

[25]  W. Bradley,et al.  Polymyositis: its presentation, morbidity and mortality. , 1975, Brain : a journal of neurology.

[26]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.

[27]  A. Bohan,et al.  Polymyositis and dermatomyositis (first of two parts). , 1975, The New England journal of medicine.